Related Experiment Videos
Dexamethasone potentiates NMDA receptor-mediated neuronal injury in the postnatal rat
1Johns Hopkins University School of Medicine, Baltimore, MD.
Insights
Dexamethasone pretreatment enhances N-methyl-D-aspartate (NMDA) neurotoxicity in young rats. This effect is dose-dependent and time-sensitive, highlighting glucocorticoid influence on excitotoxicity.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Excitatory amino acid receptors play a crucial role in neuronal function and excitotoxicity.
- Glucocorticoids are known to modulate various physiological processes, including neuronal responses.
Purpose of the Study:
- To investigate the impact of dexamethasone on neurotoxicity mediated by excitatory amino acid receptors in the developing rat brain.
- To determine the specific receptor subtypes and temporal parameters involved in dexamethasone's effect on excitotoxicity.
Main Methods:
- Neonatal rats (7-day-old) were pretreated with dexamethasone before intrastriatal injection of excitotoxins.
- Neurotoxicity was assessed following administration of N-methyl-D-aspartate (NMDA), AMPA, or kainate.
- Dose-dependency and timing of dexamethasone administration were evaluated.
- Quantitative receptor autoradiography was used to measure NMDA-sensitive glutamate receptor binding.
Main Results:
- Dexamethasone pretreatment significantly enhanced NMDA-induced neurotoxicity.
- This enhancement was NMDA-specific, as AMPA and kainate receptor-mediated toxicity were unaffected.
- The neurotoxic effect was dose-dependent and critically dependent on the timing of dexamethasone administration (1 hour prior).
- Neither aldosterone nor mepacrine affected excitotoxicity.
- Dexamethasone did not alter NMDA-sensitive glutamate receptor binding in vitro or in vivo.
Conclusions:
- Synthetic glucocorticoids like dexamethasone can exacerbate NMDA receptor-mediated neurotoxicity in the developing brain.
- The observed effect is receptor-specific and highly dependent on the temporal administration of the glucocorticoid.
- The mechanism does not appear to involve direct modulation of NMDA receptor binding, suggesting indirect pathways.
Abstract:
The present study investigated the effect of a synthetic glucocorticoid, dexamethasone, on excitatory amino acid receptor-mediated neurotoxicity in the 7-day-old rat. Pretreatment with dexamethasone (0.7 mg/kg i.p.) 1 h prior to unilateral intrastriatal injection of excitotoxin enhanced damage resulting from N-methyl-D-aspartate (NMDA), but not alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), or kainate receptor activation. The glucocorticoid-induced enhancement of NMDA toxicity was dose dependent. The time of dexamethasone administration appeared critical since only treatment 1 h prior to, but not 24 h prior to, simultaneously with, or 1 h after NMDA injection, affected toxicity. The administration of the adrenal mineralocorticoid aldosterone, or the phospholipase A2 inhibitor mepacrine, did not affect excitotoxicity. Quantitative receptor autoradiography was performed to assess the effect of dexamethasone on NMDA-sensitive [3H]glutamate receptor binding. Neither pretreatment in vivo nor the addition of dexamethasone in vitro affected NMDA-sensitive binding in the striatum. Possible explanations for these observations are discussed.